Search
for
Sort by
Research 61–90 of 1000+
- Hair graying and loss induced by imatinib mesylate
- Periocular Manifestations of Afatinib Therapy
- Hair Growth After Gefitinib Treatment
- Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
- Ponatinib-induced pityriasis rubra pilaris-like adnexal dysmaturation: A case report
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report
- Anti-Acne Agents Attenuate FGFR2 Signal Transduction in Acne
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- An unusual terminal hair growth on the nose tip associated with gefitinib therapy
- Prevention of erlotinib-induced folliculitis with doxycycline
- Nilotinib-Induced Keratosis Pilaris
- Dermatologic adverse events in EGFR-TKIs: A real-world analysis.
- 014 Tyrosine Kinase 2 Inhibition Ameliorates the Phenotype of Lesional Alopecia Areata Scalp Skin Ex Vivo, and Reverses the Induction of Human Alopecia Areata in a Humanized Mouse Model
- MicroRNA control of signal transduction
- A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa$^{(R)}$)
- Non-small cell lung carcinoma spheroid models in agarose microwells for drug response studies
- 3D organotypic skin models recapitulate autoantibody-driven pemphigus pathomechanisms and targeted therapeutic response
- Sorting Out the Seeming Increase in Lung Cancer in Women Who Have Never Smoked
- Contemporary drug synthesis
- Improving the treatment of bacterial infections caused by multidrug-resistant bacteria through drug repositioning
- Premature hair graying: a multifaceted phenomenon
- Drug Repurposing Patent Applications April–June 2021
- Localizing the ROS Signal
- Janus Kinase inhibitors in dermatology: a review
- The Role of Janus Kinase Inhibitors in Dermatology
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study